(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PROGEN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

PROGEN

ST13

US500000097403817

Class

1, 5

Filing

97403817

Registration

7524017

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

21

Latest update

10/01/2024

Trademark type

Combined

Nice classes

1, 5

Filing date

05/10/2022

Registration date

10/01/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/01/2024

Last transaction

10/01/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

06/22/2022

First use in commerce

06/22/2022

Drawing code

5

Owner type

99

Owner location

Heidelberg, DE

Examiner

COLEMAN, CIMMERIAN

Law office

N60

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of of the letters PRO in green and the letters GEN in blue whereby the G overlaps with the O.

Holders and representatives

Holders

PROGEN Biotechnik GmbH

Representatives

Alexandra Beierlein SCHUMANN BURGHART LLP

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Antibody research reagents and density gradient media for use in scientific or medical research; chemical solutions and preparations consisting of proteinspeptides and amino acids and reagents for scientific and research use in connection with medical and biological research and drug development

Class 5

Pharmaceutical preparations for diagnosing infectious diseasesautoimmune diseasestumorsimmune system defectsgrowth factor deficiencies; and medical diagnostic reagent kits comprised essentially of pharmaceuticalsswabssticksslidesfor diagnosing the aforementioned conditions

Publications

History of USPTO decisions and trademark events.

21 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/01/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

10/01/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

08/26/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/26/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/23/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/22/2024

IUAF

USE AMENDMENT FILED

06/27/2024

EISU

TEAS STATEMENT OF USE RECEIVED

06/27/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

06/18/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/23/2024

PUBO

PUBLISHED FOR OPPOSITION

04/23/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/03/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/21/2024

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

03/08/2024

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

09/08/2023

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

03/03/2023

GNSL

LETTER OF SUSPENSION E-MAILED

03/03/2023

CNSL

SUSPENSION LETTER WRITTEN

03/03/2023

DOCK

ASSIGNED TO EXAMINER

02/27/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/16/2022

NWAP

NEW APPLICATION ENTERED

05/13/2022

Continuous trademark protection

Get notified about every new filing that threatens PROGEN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.